Lyra Therapeutics【LYRA】株式ニュース

名称	銘柄コード	市場	種別
Lyra Therapeutics Inc	LYRA	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0004	-0.16%	0.2576	19:04:58

始値	安値	高値	終値	前日終値
				0.258

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/19	05:06	EDGAR2	Form 8-K - Current report
2024/6/15	05:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/15	05:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/15	05:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/08	05:15	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/5/21	22:15	EDGAR2	Form 8-K - Current report
2024/5/21	22:14	GLOBE	Lyra Therapeutics Announces Cost-Cutting Measures to..
2024/5/06	20:59	GLOBE	Lyra Therapeutics Reports Topline Results from Phase 3..
2024/5/01	05:04	GLOBE	Lyra Therapeutics Reports First Quarter 2024 Financial..
2024/4/27	05:51	GLOBE	Lyra Therapeutics Announces Inducement Grants Under Nasdaq..
2024/3/22	05:01	GLOBE	Lyra Therapeutics Reports Fourth Quarter and Full Year 2023..
2024/3/02	06:01	GLOBE	Lyra Therapeutics Announces Inducement Grant Under Nasdaq..
2024/2/15	23:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	10:35	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	08:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	06:51	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/15	06:18	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	06:34	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/02	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/02	06:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/08	20:13	EDGAR2	Form 8-K - Current report
2023/12/28	20:40	EDGAR2	Form 8-K - Current report
2023/12/19	06:16	EDGAR2	Form 8-K - Current report
2023/11/17	07:00	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2023/11/14	07:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/08	06:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08	06:09	EDGAR2	Form 8-K - Current report
2023/11/08	06:01	GLOBE	Lyra Therapeutics Reports Third Quarter 2023 Financial..
2023/11/07	21:00	GLOBE	Lyra Therapeutics to Participate in Upcoming Investor..
2023/10/16	20:00	GLOBE	Lyra Therapeutics Announces Appointment of Ronan O’Brien as..
2023/9/13	05:01	EDGAR2	Form 8-K - Current report
2023/9/12	20:00	GLOBE	Lyra Therapeutics Announces Positive Topline Results from..
2023/9/06	21:00	GLOBE	Lyra Therapeutics to Participate in Upcoming Investor..
2023/9/02	05:03	EDGAR2	Form 8-K - Current report
2023/9/02	05:01	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/29	20:00	GLOBE	Lyra Therapeutics Fully Enrolls Pivotal Phase 3 ENLIGHTEN I..
2023/8/26	05:15	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2023/8/09	05:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/09	05:03	EDGAR2	Form 8-K - Current report
2023/8/09	05:01	GLOBE	Lyra Therapeutics Reports Second Quarter 2023 Financial..
2023/7/15	05:06	EDGAR2	Form 8-K - Current report
2023/7/13	20:30	GLOBE	Lyra Therapeutics to Present at William Blair Virtual..
2023/7/13	07:36	EDGAR2	Form 4/A - Statement of changes in beneficial ownership of..
2023/7/08	05:44	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/7/06	10:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/06	10:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/7/06	10:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/6/29	05:06	EDGAR2	Form S-3 - Registration statement under Securities Act of..